Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2003 Sep;95(9):853–861.

Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy.

Terri J Menke 1, Thomas P Giordano 1, Linda Rabeneck 1
PMCID: PMC2594468  PMID: 14527053

Abstract

In the highly active antiretroviral therapy (HAART) era, U.S. African-American and Hispanic patients with HIV use HAART less, but emergency and inpatient services more, than white patients. We evaluated whether these patterns existed in the pre-HAART era. Data from prospective cohort studies of 462 male Veterans Affairs patients and 1,309 male patients from the AIDS Costs and Services Utilization Survey were combined. Resource utilization of white, African-American, and Hispanic men was compared. Compared to whites, African Americans were more likely to visit the emergency department and less likely to have mental health, home health, and dental visits; had fewer outpatient and substance abuse treatment visits; and had more inpatient nights. Hispanics were less likely to have mental health and home health visits, and had more inpatient nights. Whites used prescription drugs more than African Americans or Hispanics, but antiretrovirals were equally used. Lower access to HAART for African-American and Hispanic patients is a new phenomenon, not a continuation of pre-HAART patterns, while the undesirable patterns of emergency and outpatient provider resource utilization in the HAART era are a continuation of pre-HAART patterns. Undesirable resource utilization patterns by African-American and Hispanic populations need urgent attention.

Full text

PDF
853

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen R., Bozzette S., Shapiro M., St Clair P., Morton S., Crystal S., Goldman D., Wenger N., Gifford A., Leibowitz A. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000 Jun;35(2):389–416. [PMC free article] [PubMed] [Google Scholar]
  2. Ayanian J. Z., Cleary P. D., Weissman J. S., Epstein A. M. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999 Nov 25;341(22):1661–1669. doi: 10.1056/NEJM199911253412206. [DOI] [PubMed] [Google Scholar]
  3. Bozzette S. A., Phillips B., Asch S., Gifford A. L., Lenert L., Menke T., Ortiz E., Owens D., Deyton L. Quality Enhancement Research Initiative for human immunodeficiency virus/acquired immunodeficiency syndrome: framework and plan. HIV-QUERI Executive Committee. Med Care. 2000 Jun;38(6 Suppl 1):I60–I69. doi: 10.1097/00005650-200006001-00007. [DOI] [PubMed] [Google Scholar]
  4. Burnam M. A., Bing E. G., Morton S. C., Sherbourne C., Fleishman J. A., London A. S., Vitiello B., Stein M., Bozzette S. A., Shapiro M. F. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001 Aug;58(8):729–736. doi: 10.1001/archpsyc.58.8.729. [DOI] [PubMed] [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC) HIV and AIDS--United States, 1981-2000. MMWR Morb Mortal Wkly Rep. 2001 Jun 1;50(21):430–434. [PubMed] [Google Scholar]
  6. Cockburn J., Pit S. Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations--a questionnaire study. BMJ. 1997 Aug 30;315(7107):520–523. doi: 10.1136/bmj.315.7107.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coulter I. D., Marcus M., Freed J. R., Der-Martirosian C., Cunningham W. E., Andersen R. M., Maas W. R., Garcia I., Schneider D. A., Genovese B. Use of dental care by HIV-infected medical patients. J Dent Res. 2000 Jun;79(6):1356–1361. doi: 10.1177/00220345000790060201. [DOI] [PubMed] [Google Scholar]
  8. Crystal S., Sambamoorthi U., Merzel C. The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995 Oct;30(4):593–614. [PMC free article] [PubMed] [Google Scholar]
  9. Cunningham W. E., Markson L. E., Andersen R. M., Crystal S. H., Fleishman J. A., Golin C., Gifford A., Liu H. H., Nakazono T. T., Morton S. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):115–123. doi: 10.1097/00042560-200010010-00005. [DOI] [PubMed] [Google Scholar]
  10. Easterbrook P. J., Keruly J. C., Creagh-Kirk T., Richman D. D., Chaisson R. E., Moore R. D. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA. 1991 Nov 20;266(19):2713–2718. [PubMed] [Google Scholar]
  11. Fleishman J. A., Hsia D. C., Hellinger F. J. Correlates of medical service utilization among people with HIV infection. Health Serv Res. 1994 Dec;29(5):527–548. [PMC free article] [PubMed] [Google Scholar]
  12. Fleishman J. A. Utilization of home care among people with HIV infection. Health Serv Res. 1997 Jun;32(2):155–175. [PMC free article] [PubMed] [Google Scholar]
  13. Giordano Thomas P., White A. Clinton, Jr, Sajja Prasuna, Graviss Edward A., Arduino Roberto C., Adu-Oppong Ahmed, Lahart Christopher J., Visnegarwala Fehmida. Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):399–405. doi: 10.1097/00126334-200304010-00009. [DOI] [PubMed] [Google Scholar]
  14. Graham N. M., Jacobson L. P., Kuo V., Chmiel J. S., Morgenstern H., Zucconi S. L. Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992. J Clin Epidemiol. 1994 Sep;47(9):1003–1012. doi: 10.1016/0895-4356(94)90115-5. [DOI] [PubMed] [Google Scholar]
  15. Gross Robert, Bilker Warren B., Friedman Harvey M., Coyne James C., Strom Brian L. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS. 2002 Sep 6;16(13):1835–1837. doi: 10.1097/00002030-200209060-00021. [DOI] [PubMed] [Google Scholar]
  16. Katz M. H., Cunningham W. E., Fleishman J. A., Andersen R. M., Kellogg T., Bozzette S. A., Shapiro M. F. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Ann Intern Med. 2001 Oct 16;135(8 Pt 1):557–565. doi: 10.7326/0003-4819-135-8_part_1-200110160-00006. [DOI] [PubMed] [Google Scholar]
  17. Lucas G. M., Chaisson R. E., Moore R. D. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999 Jul 20;131(2):81–87. doi: 10.7326/0003-4819-131-2-199907200-00002. [DOI] [PubMed] [Google Scholar]
  18. Maisels L., Steinberg J., Tobias C. An investigation of why eligible patients do not receive HAART. AIDS Patient Care STDS. 2001 Apr;15(4):185–191. doi: 10.1089/10872910151133701. [DOI] [PubMed] [Google Scholar]
  19. Mascarenhas A. K., Smith S. R. Access and use of specific dental services in HIV disease. J Public Health Dent. 2000 Summer;60(3):172–181. doi: 10.1111/j.1752-7325.2000.tb03324.x. [DOI] [PubMed] [Google Scholar]
  20. Menke T. J., Rabeneck L., Hartigan P. M., Simberkoff M. S., Wray N. P. Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans Affairs. Inquiry. 2000 Spring;37(1):61–74. [PubMed] [Google Scholar]
  21. Moore R. D., Hidalgo J., Sugland B. W., Chaisson R. E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 16;324(20):1412–1416. doi: 10.1056/NEJM199105163242006. [DOI] [PubMed] [Google Scholar]
  22. Moore R. D., Stanton D., Gopalan R., Chaisson R. E. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994 Mar 17;330(11):763–768. doi: 10.1056/NEJM199403173301107. [DOI] [PubMed] [Google Scholar]
  23. Palacio Herminia, Kahn James G., Richards T. Anne, Morin Stephen F. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002 May-Jun;117(3):233–232. doi: 10.1093/phr/117.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rabeneck L., Menke T., Simberkoff M. S., Hartigan P. M., Dickinson G. M., Jensen P. C., George W. L., Goetz M. B., Wray N. P. Using the national registry of HIV-infected veterans in research: lessons for the development of disease registries. J Clin Epidemiol. 2001 Dec;54(12):1195–1203. doi: 10.1016/s0895-4356(01)00397-3. [DOI] [PubMed] [Google Scholar]
  25. Shapiro M. F., Morton S. C., McCaffrey D. F., Senterfitt J. W., Fleishman J. A., Perlman J. F., Athey L. A., Keesey J. W., Goldman D. P., Berry S. H. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999 Jun 23;281(24):2305–2315. doi: 10.1001/jama.281.24.2305. [DOI] [PubMed] [Google Scholar]
  26. Siegel K., Karus D., Schrimshaw E. W. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care. 2000 Aug;12(4):423–434. doi: 10.1080/09540120050123828. [DOI] [PubMed] [Google Scholar]
  27. Smith S. R., Kirking D. M. Access and use of medications in HIV disease. Health Serv Res. 1999 Apr;34(1 Pt 1):123–144. [PMC free article] [PubMed] [Google Scholar]
  28. Stein M. D., Hanna L. Use of mental health services by HIV-infected women. J Womens Health. 1997 Oct;6(5):569–574. doi: 10.1089/jwh.1997.6.569. [DOI] [PubMed] [Google Scholar]
  29. Turner B. J., Fleishman J. A., Wenger N., London A. S., Burnam M. A., Shapiro M. F., Bing E. G., Stein M. D., Longshore D., Bozzette S. A. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med. 2001 Sep;16(9):625–633. doi: 10.1046/j.1525-1497.2001.016009625.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  31. Whitman S., Murphy J., Cohen M., Sherer R. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997. Arch Intern Med. 2000 Feb 14;160(3):365–369. doi: 10.1001/archinte.160.3.365. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES